Adrenoleukodystrophy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(16 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Adrenoleukodystrophy}}
{{CMG}} '''Associate Editor-In-Chief:''' {{Ibtisam}}
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''
{{SK}} Adrenoleucodystrophy, Adrenomyeloneuropathy, Bronze Schilder disease, Siemerling-Creutzfeldt disease, Addison-Schilder syndrome


{{Infobox_Disease |
{{Infobox_Disease |
Line 14: Line 20:
   MeshID        = D000326 |
   MeshID        = D000326 |
}}
}}
{{Adrenoleukodystrophy}}
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''
{{CMG}}
{{SK}}: Adrenoleucodystrophy, adrenomyeloneuropathy, bronze schilder disease, siemerling-creutzfeldt disease, addison-schilder syndrome


==[[Adrenoleukodystrophy overview|Overview]]==
==[[Adrenoleukodystrophy overview|Overview]]==
Line 26: Line 25:
==[[Adrenoleukodystrophy historical perspective|Historical Perspective]]==
==[[Adrenoleukodystrophy historical perspective|Historical Perspective]]==


==[[Adrenoleukodystrophy classification|Classifications]]==
==[[Adrenoleukodystrophy classification|Classification]]==


==[[Adrenoleukodystrophy pathophysiology|Pathophysiology]]==
==[[Adrenoleukodystrophy pathophysiology|Pathophysiology]]==
Line 32: Line 31:
==[[Adrenoleukodystrophy causes|Causes]]==
==[[Adrenoleukodystrophy causes|Causes]]==


==[[Adrenoleukodystrophy differential diagnosis|Differentiating Adrenoleukodystrophy from other Disorders]]==
==[[Adrenoleukodystrophy differential diagnosis|Differentiating Adrenoleukodystrophy from Other Diseases]]==


==[[Adrenoleukodystrophy epidemiology and demographics|Epidemiology and Demographics]]==
==[[Adrenoleukodystrophy epidemiology and demographics|Epidemiology and Demographics]]==
Line 43: Line 42:


==Diagnosis==
==Diagnosis==
[[Adrenoleukodystrophy history and symptoms|History and Symptoms]] | [[Adrenoleukodystrophy physical examination|Physical Examination]] | [[Adrenoleukodystrophy laboratory findings|Laboratory Findings]] | [[Adrenoleukodystrophy electroencephalogram|Electroencephalogram]] | [[Adrenoleukodystrophy x ray|X Rays]] | [[Adrenoleukodystrophy CT|CT]] | [[Adrenoleukodystrophy MRI|MRI]] | [[Adrenoleukodystrophy echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Adrenoleukodystrophy other imaging findings|Other Imaging Findings]] | [[Adrenoleukodystrophy other diagnostic studies|Other Diagnostic Studies]]
[[Adrenoleukodystrophy history and symptoms|History and Symptoms]] | [[Adrenoleukodystrophy physical examination|Physical Examination]] | [[Adrenoleukodystrophy laboratory findings|Laboratory Findings]] | [[Adrenoleukodystrophy electrocardiogram|Electrocardiogram]] | [[Adrenoleukodystrophy x ray|X Ray]] | [[Adrenoleukodystrophy CT|CT]] | [[Adrenoleukodystrophy MRI|MRI]] | [[Adrenoleukodystrophy echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Adrenoleukodystrophy other imaging findings|Other Imaging Findings]] | [[Adrenoleukodystrophy other diagnostic studies|Other Diagnostic Studies]]


==Treatment==
==Treatment==
[[Adrenoleukodystrophy medical therapy|Medical Therapy]] | [[Adrenoleukodystrophy primary prevention|Primary Prevention]] | [[Adrenoleukodystrophy secondary prevention|Secondary Prevention]] | [[Adrenoleukodystrophy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Adrenoleukodystrophy future or investigational therapies|Future or Investigational Therapies]]
[[Adrenoleukodystrophy medical therapy|Medical Therapy]] | [[Adrenoleukodystrophy surgery|Surgery]] | [[Adrenoleukodystrophy primary prevention|Primary Prevention]] | [[Adrenoleukodystrophy secondary prevention|Secondary Prevention]] | [[Adrenoleukodystrophy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Adrenoleukodystrophy future or investigational therapies|Future or Investigational Therapies]]


==Case Studies==
==Case Studies==
Line 52: Line 51:


==External links==
==External links==
* [http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowSection&rid=gnd.section.226 Adrenoleukodystrophy] at [[National Center for Biotechnology Information]]
 
* [http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=1&f=G&l=50&d=PTXT&p=1&S1=5331009.PN.&OS=pn/5331009&RS=PN/5331009/ US Patent 5,331,009] — Patent to Croda International Plc on treating ALD with special oil composition inspired by Augusto Odone
*[http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowSection&rid=gnd.section.226 Adrenoleukodystrophy] at [[National Center for Biotechnology Information]]
*[http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=1&f=G&l=50&d=PTXT&p=1&S1=5331009.PN.&OS=pn/5331009&RS=PN/5331009/ US Patent 5,331,009] — Patent to Croda International Plc on treating ALD with special oil composition inspired by Augusto Odone
 
==References==
{{reflist|2}}


{{Metabolic pathology}}
{{Metabolic pathology}}
{{Peroxisomal disorders}}
{{Peroxisomal disorders}}
[[Category:Endocrinology]]


[[de:Adrenoleukodystrophie]]
[[de:Adrenoleukodystrophie]]
Line 72: Line 77:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Disease]]
[[Category:Genetic disorders]]
[[Category:Metabolic disorders]]
[[Category:Overview complete]]

Latest revision as of 15:05, 24 August 2020

Adrenoleukodystrophy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adrenoleukodystrophy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adrenoleukodystrophy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adrenoleukodystrophy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adrenoleukodystrophy

CDC on Adrenoleukodystrophy

Adrenoleukodystrophy in the news

Blogs on Adrenoleukodystrophy

Directions to Hospitals Treating Adrenoleukodystrophy

Risk calculators and risk factors for Adrenoleukodystrophy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief: Ibtisam Ashraf, M.B.B.S.[2]

For patient information click here

Synonyms and keywords: Adrenoleucodystrophy, Adrenomyeloneuropathy, Bronze Schilder disease, Siemerling-Creutzfeldt disease, Addison-Schilder syndrome

Adrenoleukodystrophy
ICD-10 E71.3
ICD-9 330.0, 277.86
OMIM 300100 202370
DiseasesDB 292
MeSH D000326

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adrenoleukodystrophy from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

External links

References

Template:Metabolic pathology Template:Peroxisomal disorders

de:Adrenoleukodystrophie hr:Adrenoleukodistrofija it:Adrenoleucodistrofia he:ALD fi:ALD sv:Adrenoleukodystrofi


Template:WikiDoc Sources